HUMA

Latest SEC Filings & News for HUMA

1 most recent filing and news item mentioning HUMA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/HUMA/news?limit=20"

Pull HUMA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 10, 2026Positive

Humacyte's ATEV met Phase 3 primary endpoint vs AV fistula in dialysis study

Humacyte announced positive interim results from its V012 Phase 3 study showing the acellular tissue engineered vessel (ATEV) achieved superior catheter-free days (91 more days, p=0.00070) compared to standard autologous AV fistula in female dialysis patients. The company plans t

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.